In addition, approximately 5% of patients harbor partial tandem duplications within the KMT2A gene (KMT2A-PTD) demonstrating a similar biology as described for KMT2Ar-dependent AML as described below [128,129]. Here, KMT2A is linked to acute myeloid leukemia.